It’s a bit confusing. UBS still recommends “buy,” even though they lowered the price target from $175 to $170. At the same time, there are significant changes happening. Elliott just bought a $4B stake and is pushing for a focus on core brands and streamlining operations. As a potential shareholder, I’m curious how all this pressure and these moves might impact the investment.
There are no replies in this thread yet. Be the first to post a reply below: